EBS CIK: 1367644

Emergent BioSolutions Inc.

  • United States
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
1.27
FY22:
1.21
FY23:
0.68
FY24:
0.60
FY25:
0.66
(positive)
Change from FY21 to FY25
billions USD
FY21:
1.69
FY22:
1.96
FY23:
1.14
FY24:
0.79
FY25:
0.66
Total assets
Change from FY21 to FY25
billions USD
FY21:
2.96
FY22:
3.17
FY23:
1.82
FY24:
1.39
FY25:
1.32

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.37
FY22:
1.23
FY23:
0.65
FY24:
0.16
FY25:
0.13
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.97
FY22:
0.55
FY23:
0.52
FY24:
0.74
FY25:
0.66
(positive)
Change from FY21 to FY25
billions USD
FY21:
1.61
FY22:
1.39
FY23:
0.65
FY24:
0.48
FY25:
0.52
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
2.96
FY22:
3.17
FY23:
1.82
FY24:
1.39
FY25:
1.32

All amounts in billions USD Data source:SEC EDGAR